151 related articles for article (PubMed ID: 28067880)
1. A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database.
Kurita N; Gosho M; Yokoyama Y; Kato T; Obara N; Sakata-Yanagimoto M; Hasegawa Y; Uchida N; Takahashi S; Kouzai Y; Atsuta Y; Kurata M; Ichinohe T; Chiba S
Bone Marrow Transplant; 2017 Apr; 52(4):574-579. PubMed ID: 28067880
[TBL] [Abstract][Full Text] [Related]
2. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
Nishida T; Kobayashi T; Sawa M; Masuda S; Shibasaki Y; Goto T; Fukuhara N; Fujii N; Ikegame K; Sugita J; Ikeda T; Kuwatsuka Y; Suzuki R; Najima Y; Doki N; Kato T; Inagaki Y; Utsu Y; Aotsuka N; Masuko M; Terakura S; Onishi Y; Maeda Y; Okada M; Teshima T; Murata M
Ann Hematol; 2021 Mar; 100(3):743-752. PubMed ID: 33427909
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.
Okada M; Tasaka T; Ikegame K; Aotsuka N; Kobayashi T; Najima Y; Matsuhashi Y; Wada H; Tokunaga H; Masuda S; Utsu Y; Yoshihara S; Kaida K; Daimon T; Ogawa H
Eur J Haematol; 2018 Apr; 100(4):335-343. PubMed ID: 29168236
[TBL] [Abstract][Full Text] [Related]
4. Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study.
Okada M; Yoshihara S; Taniguchi K; Kaida K; Ikegame K; Kato R; Tamaki H; Inoue T; Soma T; Kai S; Kato S; Ogawa H
Biol Blood Marrow Transplant; 2012 Apr; 18(4):633-9. PubMed ID: 21867667
[TBL] [Abstract][Full Text] [Related]
5. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of intrabone single unit cord blood transplantation for hematological malignancies.
Murata M; Maeda Y; Masuko M; Onishi Y; Endo T; Terakura S; Ishikawa Y; Iriyama C; Ushijima Y; Goto T; Fujii N; Tanimoto M; Kobayashi H; Shibasaki Y; Fukuhara N; Inamoto Y; Suzuki R; Kodera Y; Matsushita T; Kiyoi H; Naoe T; Nishida T
Cancer Sci; 2017 Aug; 108(8):1634-1639. PubMed ID: 28582607
[TBL] [Abstract][Full Text] [Related]
7. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
Frassoni F; Gualandi F; Podestà M; Raiola AM; Ibatici A; Piaggio G; Sessarego M; Sessarego N; Gobbi M; Sacchi N; Labopin M; Bacigalupo A
Lancet Oncol; 2008 Sep; 9(9):831-9. PubMed ID: 18693069
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol.
Goto T; Murata M; Terakura S; Nishida T; Adachi Y; Ushijima Y; Shimada K; Ishikawa Y; Hayakawa F; Nishio N; Nishiwaki S; Hirakawa A; Kato K; Takahashi Y; Kiyoi H
Medicine (Baltimore); 2018 Apr; 97(17):e0449. PubMed ID: 29702996
[TBL] [Abstract][Full Text] [Related]
9. Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study.
Marini C; Podestà M; Massollo M; Capitanio S; Fiz F; Morbelli S; Brignone M; Bacigalupo A; Piana M; Frassoni F; Sambuceti G
J Biomed Biotechnol; 2012; 2012():767369. PubMed ID: 23093864
[TBL] [Abstract][Full Text] [Related]
10. The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases.
Frassoni F; Varaldo R; Gualandi F; Bacigalupo A; Sambuceti G; Sacchi N; Podestà M
Best Pract Res Clin Haematol; 2010 Jun; 23(2):237-44. PubMed ID: 20837336
[TBL] [Abstract][Full Text] [Related]
11. Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.
Kato K; Yoshimi A; Ito E; Oki K; Hara J; Nagatoshi Y; Kikuchi A; Kobayashi R; Nagamura-Inoue T; Kai S; Azuma H; Takanashi M; Isoyama K; Kato S;
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1814-21. PubMed ID: 21664471
[TBL] [Abstract][Full Text] [Related]
12. Double vs. single cord blood transplantation in adolescent and adult hematological malignancies with heavier body weight (≥50 kg).
Zheng CC; Zhu XY; Tang BL; Zhang XH; Zhang L; Geng LQ; Liu HL; Sun ZM
Hematology; 2018 Mar; 23(2):96-104. PubMed ID: 28795658
[TBL] [Abstract][Full Text] [Related]
13. Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.
Nakasone H; Fuji S; Yakushijin K; Onizuka M; Shinohara A; Ohashi K; Miyamura K; Uchida N; Takanashi M; Ichinohe T; Atsuta Y; Fukuda T; Ogata M;
Am J Hematol; 2017 Feb; 92(2):171-178. PubMed ID: 27880980
[TBL] [Abstract][Full Text] [Related]
14. Unrelated cord blood transplants in adults with hematologic malignancies.
Arcese W; Rocha V; Labopin M; Sanz G; Iori AP; de Lima M; Sirvent A; Busca A; Asano S; Ionescu I; Wernet P; Gluckman E;
Haematologica; 2006 Feb; 91(2):223-30. PubMed ID: 16461307
[TBL] [Abstract][Full Text] [Related]
15. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
Popat U; Mehta RS; Rezvani K; Fox P; Kondo K; Marin D; McNiece I; Oran B; Hosing C; Olson A; Parmar S; Shah N; Andreeff M; Kebriaei P; Kaur I; Yvon E; de Lima M; Cooper LJ; Tewari P; Champlin RE; Nieto Y; Andersson BS; Alousi A; Jones RB; Qazilbash MH; Bashir Q; Ciurea S; Ahmed S; Anderlini P; Bosque D; Bollard C; Molldrem JJ; Chen J; Rondon G; Thomas M; Miller L; Wolpe S; Simmons P; Robinson S; Zweidler-McKay PA; Shpall EJ
Blood; 2015 May; 125(19):2885-92. PubMed ID: 25778529
[TBL] [Abstract][Full Text] [Related]
16. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
Avery S; Voss MH; Gonzales AM; Lubin M; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Hedvat CV; Stevens CE; Barker JN
Bone Marrow Transplant; 2012 Aug; 47(8):1056-60. PubMed ID: 22139066
[TBL] [Abstract][Full Text] [Related]
17. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
18. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
[TBL] [Abstract][Full Text] [Related]
19. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
